| pubmed-article:9050359 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9050359 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:9050359 | lifeskim:mentions | umls-concept:C0026769 | lld:lifeskim |
| pubmed-article:9050359 | lifeskim:mentions | umls-concept:C0017337 | lld:lifeskim |
| pubmed-article:9050359 | lifeskim:mentions | umls-concept:C0031640 | lld:lifeskim |
| pubmed-article:9050359 | lifeskim:mentions | umls-concept:C1882417 | lld:lifeskim |
| pubmed-article:9050359 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:9050359 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:9050359 | pubmed:dateCreated | 1997-3-25 | lld:pubmed |
| pubmed-article:9050359 | pubmed:abstractText | Susceptibility to multiple sclerosis (MS) is widely held to have a genetic component. Possible candidate genes conferring this susceptibility include those coding for proteins specific to central nervous system (CNS) myelin. 2',3'-cyclic nucleotide-3'-phosphodiesterase (CNPase) is an enzyme found at high concentrations in CNS myelin, however its function is unknown. The amino acid sequence of CNPase shows a C-terminal motif characteristic of proteins involved in signal transduction pathways, suggesting a key role in myelin function. We have analysed the entire expressed sequence of the human CNPase gene in patients with multiple sclerosis and in healthy controls using single strand conformation polymorphism (SSCP) analysis. Nine previously undescribed mutations were detected, most of these occurred with equal frequency in both groups. However, a T-->C transition at nucleotide position 4306 in the region of the gene coding for the 3' untranslated region of the mature mRNA was found in a homozygous form in two out of 54 patients but in none of 100 controls. While the significance of this is unclear, it would appear unlikely that mutations in the expressed regions of the human CPNase gene contribute to genetic susceptibility to MS in the majority of sufferers. | lld:pubmed |
| pubmed-article:9050359 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9050359 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9050359 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9050359 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9050359 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9050359 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9050359 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:9050359 | pubmed:issn | 1352-4585 | lld:pubmed |
| pubmed-article:9050359 | pubmed:author | pubmed-author:ThompsonR JRJ | lld:pubmed |
| pubmed-article:9050359 | pubmed:author | pubmed-author:PriceS ESE | lld:pubmed |
| pubmed-article:9050359 | pubmed:author | pubmed-author:DouglasA JAJ | lld:pubmed |
| pubmed-article:9050359 | pubmed:author | pubmed-author:HinksL JLJ | lld:pubmed |
| pubmed-article:9050359 | pubmed:author | pubmed-author:MasonC RCR | lld:pubmed |
| pubmed-article:9050359 | pubmed:author | pubmed-author:DwarswaardAA | lld:pubmed |
| pubmed-article:9050359 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9050359 | pubmed:volume | 2 | lld:pubmed |
| pubmed-article:9050359 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9050359 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9050359 | pubmed:pagination | 215-21 | lld:pubmed |
| pubmed-article:9050359 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9050359 | pubmed:meshHeading | pubmed-meshheading:9050359-... | lld:pubmed |
| pubmed-article:9050359 | pubmed:meshHeading | pubmed-meshheading:9050359-... | lld:pubmed |
| pubmed-article:9050359 | pubmed:meshHeading | pubmed-meshheading:9050359-... | lld:pubmed |
| pubmed-article:9050359 | pubmed:meshHeading | pubmed-meshheading:9050359-... | lld:pubmed |
| pubmed-article:9050359 | pubmed:meshHeading | pubmed-meshheading:9050359-... | lld:pubmed |
| pubmed-article:9050359 | pubmed:meshHeading | pubmed-meshheading:9050359-... | lld:pubmed |
| pubmed-article:9050359 | pubmed:meshHeading | pubmed-meshheading:9050359-... | lld:pubmed |
| pubmed-article:9050359 | pubmed:meshHeading | pubmed-meshheading:9050359-... | lld:pubmed |
| pubmed-article:9050359 | pubmed:meshHeading | pubmed-meshheading:9050359-... | lld:pubmed |
| pubmed-article:9050359 | pubmed:meshHeading | pubmed-meshheading:9050359-... | lld:pubmed |
| pubmed-article:9050359 | pubmed:meshHeading | pubmed-meshheading:9050359-... | lld:pubmed |
| pubmed-article:9050359 | pubmed:meshHeading | pubmed-meshheading:9050359-... | lld:pubmed |
| pubmed-article:9050359 | pubmed:meshHeading | pubmed-meshheading:9050359-... | lld:pubmed |
| pubmed-article:9050359 | pubmed:meshHeading | pubmed-meshheading:9050359-... | lld:pubmed |
| pubmed-article:9050359 | pubmed:meshHeading | pubmed-meshheading:9050359-... | lld:pubmed |
| pubmed-article:9050359 | pubmed:meshHeading | pubmed-meshheading:9050359-... | lld:pubmed |
| pubmed-article:9050359 | pubmed:year | 1996 | lld:pubmed |
| pubmed-article:9050359 | pubmed:articleTitle | Analysis of polymorphisms of the 2',3'-cyclic nucleotide-3'-phosphodiesterase gene in patients with multiple sclerosis. | lld:pubmed |
| pubmed-article:9050359 | pubmed:affiliation | University Clinical Biochemistry, Southampton General Hospital, UK. | lld:pubmed |
| pubmed-article:9050359 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9050359 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9050359 | lld:pubmed |
